Direkt zum Inhalt
Merck
  • A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, vitamin B12) reduces oxidative stress markers in a rat model of pregnancy induced hypertension.

A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, vitamin B12) reduces oxidative stress markers in a rat model of pregnancy induced hypertension.

PloS one (2014-11-19)
Nisha G Kemse, Anvita A Kale, Sadhana R Joshi
ZUSAMMENFASSUNG

Our earlier studies have highlighted that an altered one carbon metabolism (vitamin B12, folic acid, and docosahexaenoic acid) is associated with preeclampsia. Preeclampsia is also known to be associated with oxidative stress and inflammation. The current study examines whether maternal folic acid, vitamin B12 and omega-3 fatty acid supplementation given either individually or in combination can ameliorate the oxidative stress markers in a rat model of pregnancy induced hypertension (PIH). Pregnant Wistar rats were assigned to control and five treatment groups: PIH; PIH + vitamin B12; PIH + folic acid; PIH + Omega-3 fatty acids and PIH + combined micronutrient supplementation (vitamin B12 + folic acid + omega-3 fatty acids). L-Nitroarginine methylester (L-NAME; 50 mg/kg body weight/day) was used to induce hypertension during pregnancy. Blood Pressure (BP) was recorded during pregnancy and dams were dissected at d20 of gestation. Animals from the PIH group demonstrated higher (p<0.01 for both) systolic and diastolic BP; lower (p<0.01) pup weight; higher dam plasma homocysteine (p<0.05) and dam and offspring malondialdehyde (MDA) (p<0.01), lower (p<0.05) placental and offspring liver DHA and higher (p<0.01) tumor necrosis factor-alpha (TNF-ά) levels as compared to control. Individual micronutrient supplementation did not offer much benefit. In contrast, combined supplementation lowered systolic BP, homocysteine, MDA and placental TNF-ά levels in dams and liver MDA and protein carbonyl in the offspring as compared to PIH group. Key constituents of one carbon cycle (folic acid, vitamin B12 and DHA) may play a role in reducing oxidative stress and inflammation in preeclampsia.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Vitamin B12, ≥98%
Supelco
Cyanocobalamin, pharmaceutical secondary standard, certified reference material
Sigma-Aldrich
Vitamin B12, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
3,3′,5,5′-Tetramethylbenzidin, ≥99%
Supelco
Cyanocobalamin (B12), analytical standard
Sigma-Aldrich
3,3′,5,5′-Tetramethylbenzidin, ≥98% (TLC)
Sigma-Aldrich
DL-Homocystein, ≥95% (titration)
Sigma-Aldrich
3,3′,5,5′-Tetramethylbenzidin, ≥98.0% (NT)
Sigma-Aldrich
3,3′,5,5′-Tetramethylbenzidin, tablet, 1 mg substrate per tablet
Sigma-Aldrich
Cyanocobalamin, meets USP testing specifications
Supelco
DL-Homocystein, analytical standard
Cyanocobalamin, British Pharmacopoeia (BP) Assay Standard
Cyanocobalamin, European Pharmacopoeia (EP) Reference Standard
Supelco
3,3′,5,5′-Tetramethylbenzidin, standard for GC